FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026930636> ?p ?o ?g. }

• W2026930636 endingPage "1427" @default.
• W2026930636 startingPage "1421" @default.
• W2026930636 abstract "ABSTRACT Limited antimicrobial agents are available for the treatment of implant-associated infections caused by fluoroquinolone-resistant Gram-negative bacilli. We compared the activities of fosfomycin, tigecycline, colistin, and gentamicin (alone and in combination) against a CTX-M15-producing strain of Escherichia coli (Bj HDE-1) in vitro and in a foreign-body infection model. The MIC and the minimal bactericidal concentration in logarithmic phase (MBC log ) and stationary phase (MBC stat ) were 0.12, 0.12, and 8 μg/ml for fosfomycin, 0.25, 32, and 32 μg/ml for tigecycline, 0.25, 0.5, and 2 μg/ml for colistin, and 2, 8, and 16 μg/ml for gentamicin, respectively. In time-kill studies, colistin showed concentration-dependent activity, but regrowth occurred after 24 h. Fosfomycin demonstrated rapid bactericidal activity at the MIC, and no regrowth occurred. Synergistic activity between fosfomycin and colistin in vitro was observed, with no detectable bacterial counts after 6 h. In animal studies, fosfomycin reduced planktonic counts by 4 log 10 CFU/ml, whereas in combination with colistin, tigecycline, or gentamicin, it reduced counts by >6 log 10 CFU/ml. Fosfomycin was the only single agent which was able to eradicate E. coli biofilms (cure rate, 17% of implanted, infected cages). In combination, colistin plus tigecycline (50%) and fosfomycin plus gentamicin (42%) cured significantly more infected cages than colistin plus gentamicin (33%) or fosfomycin plus tigecycline (25%) ( P < 0.05). The combination of fosfomycin plus colistin showed the highest cure rate (67%), which was significantly better than that of fosfomycin alone ( P < 0.05). In conclusion, the combination of fosfomycin plus colistin is a promising treatment option for implant-associated infections caused by fluoroquinolone-resistant Gram-negative bacilli." @default.
• W2026930636 created "2016-06-24" @default.
• W2026930636 creator A5028088489 @default.
• W2026930636 creator A5028715560 @default.
• W2026930636 creator A5047650052 @default.
• W2026930636 creator A5062491787 @default.
• W2026930636 creator A5068817061 @default.
• W2026930636 date "2013-03-01" @default.
• W2026930636 modified "2023-10-18" @default.
• W2026930636 title "Activities of Fosfomycin, Tigecycline, Colistin, and Gentamicin against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Foreign-Body Infection Model" @default.
• W2026930636 cites W1628591093 @default.
• W2026930636 cites W1746486625 @default.
• W2026930636 cites W18650605 @default.
• W2026930636 cites W1894757789 @default.
• W2026930636 cites W1900386570 @default.
• W2026930636 cites W1965933012 @default.
• W2026930636 cites W1967459325 @default.
• W2026930636 cites W1970698283 @default.
• W2026930636 cites W1973179753 @default.
• W2026930636 cites W1979421702 @default.
• W2026930636 cites W1980325515 @default.
• W2026930636 cites W1983255179 @default.
• W2026930636 cites W1984417594 @default.
• W2026930636 cites W1995384415 @default.
• W2026930636 cites W1999156712 @default.
• W2026930636 cites W2000903526 @default.
• W2026930636 cites W2019111560 @default.
• W2026930636 cites W2019117332 @default.
• W2026930636 cites W2035799236 @default.
• W2026930636 cites W2056396129 @default.
• W2026930636 cites W2062595051 @default.
• W2026930636 cites W2066224020 @default.
• W2026930636 cites W2079494261 @default.
• W2026930636 cites W2085780405 @default.
• W2026930636 cites W2093440252 @default.
• W2026930636 cites W2094164655 @default.
• W2026930636 cites W2097173594 @default.
• W2026930636 cites W2103745936 @default.
• W2026930636 cites W2107697524 @default.
• W2026930636 cites W2114640639 @default.
• W2026930636 cites W2116502589 @default.
• W2026930636 cites W2118730804 @default.
• W2026930636 cites W2120614544 @default.
• W2026930636 cites W2121051550 @default.
• W2026930636 cites W2124190525 @default.
• W2026930636 cites W2137925733 @default.
• W2026930636 cites W2139986510 @default.
• W2026930636 cites W2142980821 @default.
• W2026930636 cites W2144148663 @default.
• W2026930636 cites W2144661355 @default.
• W2026930636 cites W2145595965 @default.
• W2026930636 cites W2145973757 @default.
• W2026930636 cites W2150224997 @default.
• W2026930636 cites W2153107590 @default.
• W2026930636 cites W2157512160 @default.
• W2026930636 cites W2159961513 @default.
• W2026930636 cites W2163334138 @default.
• W2026930636 cites W2164072097 @default.
• W2026930636 cites W2165496299 @default.
• W2026930636 cites W2167093953 @default.
• W2026930636 cites W2168219468 @default.
• W2026930636 cites W2168505406 @default.
• W2026930636 cites W2169291267 @default.
• W2026930636 cites W2170885587 @default.
• W2026930636 cites W87013843 @default.
• W2026930636 doi "https://doi.org/10.1128/aac.01718-12" @default.
• W2026930636 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3591882" @default.
• W2026930636 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23295934" @default.
• W2026930636 hasPublicationYear "2013" @default.
• W2026930636 type Work @default.
• W2026930636 sameAs 2026930636 @default.
• W2026930636 citedByCount "104" @default.
• W2026930636 countsByYear W20269306362013 @default.
• W2026930636 countsByYear W20269306362014 @default.
• W2026930636 countsByYear W20269306362015 @default.
• W2026930636 countsByYear W20269306362016 @default.
• W2026930636 countsByYear W20269306362017 @default.
• W2026930636 countsByYear W20269306362018 @default.
• W2026930636 countsByYear W20269306362019 @default.
• W2026930636 countsByYear W20269306362020 @default.
• W2026930636 countsByYear W20269306362021 @default.
• W2026930636 countsByYear W20269306362022 @default.
• W2026930636 countsByYear W20269306362023 @default.
• W2026930636 crossrefType "journal-article" @default.
• W2026930636 hasAuthorship W2026930636A5028088489 @default.
• W2026930636 hasAuthorship W2026930636A5028715560 @default.
• W2026930636 hasAuthorship W2026930636A5047650052 @default.
• W2026930636 hasAuthorship W2026930636A5062491787 @default.
• W2026930636 hasAuthorship W2026930636A5068817061 @default.
• W2026930636 hasBestOaLocation W20269306361 @default.
• W2026930636 hasConcept C2775832221 @default.
• W2026930636 hasConcept C2777027569 @default.
• W2026930636 hasConcept C2778897966 @default.
• W2026930636 hasConcept C2779259085 @default.
• W2026930636 hasConcept C4937899 @default.
• W2026930636 hasConcept C501593827 @default.
• W2026930636 hasConcept C86803240 @default.
• W2026930636 hasConcept C89423630 @default.

• next